Novel genome editing technologies
Broken String has raised €14M across 1 funding round from 5 investors, most recently a Series A round in Sep 2023. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-18 | Series A | €14M |
| Dieter von Holtzbrinck Ventures (DvH Ventures),Heran Partners,Illumina Ventures,Mérieux Equity Partners,Tencent |
| View deal → |
